Inovio Pharmaceuticals, Inc. (INO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 815.82M |
| Enterprise Value | 780.92M |
| P/E Ratio | -0.65 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 126.98 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.51 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.71 |
| Return On Equity | -6.66 |
Income Statement
| Revenue | 65,343 |
| Revenue/Share | 0 |
| Gross Profit | 65,343 |
| EBITDA | -81.96M |
| Net Income | -84.95M |
| Diluted EPS | -1.81 |
Balance Sheet
| Total Cash | 37.68M |
| Total Cash/Share | 0.05 |
| Total Debt | 8.7M |
| Total Debt/Equity | 1.43 |
| Current Ratio | 1.04 |
| Book Value Per Share | 0.01 |
Price History
| 52-Week Change | -42.23 |
| 52-Week High | 2.98 |
| 52-Week Low | 1.03 |
| Moving Average 50 Days | 1.19 |
| Moving Average 200 Days | 1.79 |
Statistics
| Average Volume | 2.79M |
| Shares Outstanding | 53.59M |
| % Held by Institutions | 6.69 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | January 25, 2024 |
AD
